Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Duke Health / Duke Cancer Institute

Duke Health / Duke Cancer Institute

Academic Medical Center

Appears in 1 story

Stories

Therapeutic cancer vaccines emerge from decades of development

New Capabilities

Conducting ongoing Phase 2 cancer vaccine trials

Metastatic breast cancer typically kills most patients within five years. A small group of women vaccinated in a Duke University clinical trial two decades ago have defied that prognosis entirely; all remain alive today. Researchers found these survivors still carry specialized immune cells that recognize their cancer, offering a model for why some therapeutic vaccines produce lasting results.

Updated 6 days ago